Results 101 to 110 of about 1,716,393 (201)

Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination

Introduction: Prior research explores whether seasonal and childhood vaccines mitigate the risk of SARS-CoV-2 infection. Although there are trials investigating COVID-19 infection in response to the effects of the oral poliovirus vaccine (OPV), there has
Chisom Azodoh, Lilly D. Engineer, Aditi Singh, Robin J. Larson, Yea-Jen Hsu, Erin Jackson-Ward, Brittany A. Comunale   +6 more
core   +1 more source

Boosting of Mucosal Immunity After Fractional-Dose Inactivated Poliovirus Vaccine

, 2018
BACKGROUND. Inactivated poliovirus vaccine (IPV) boosts mucosal immunity in persons previously vaccinated with oral poliovirus vaccine (OPV). We assessed whether fractional-dose IPV (fIPV, 1/5th of full dose) administered intradermally also boosts ...
Yiting Zhang, Gamage, Deepa, Ondrej Mach, Sutter, Roland W., Oberste, M. Steven, Weldon, William C., Zhang, Yiting, Gunasena, Sunethra, Mach, Ondrej, William C Weldon, Roland W Sutter, M Steven Oberste, Palihawadana, Paba, Deepa Gamage, Paba Palihawadana, Sunethra Gunasena   +15 more
core   +1 more source

Estimation of oral poliovirus vaccine effectiveness in Afghanistan, 2010-2020. [PDF]

Vaccine, 2021
Chard AN, Martinez M, Matanock A, Kassem AM.   +3 more
europepmc   +1 more source

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique. [PDF]

J Infect Dis, 2022
de Deus N, Capitine IPU, Bauhofer AFL, Marques S, Cassocera M, Chissaque A, Bero DM, Langa JP, Padama FM, Jeyaseelan V, Oberste MS, Estivariz CF, Verma H, Jani I, Mach O, Sutter RW.   +15 more
europepmc   +1 more source

Impediments to Progress Toward Polio Eradication During 2014–2024: Effectively Addressing the Current Challenges

Vaccines
When the Global Polio Eradication Initiative (GPEI) began in 1988, the year 2000 target was clearly ambitious. Nonetheless, among 20 countries with endemic wild poliovirus transmission in 2000, only Afghanistan, Nigeria and Pakistan remained endemic in ...
Steven G. F. Wassilak, Abdinoor Mohamed, John Paul Bigouette   +2 more
doaj   +1 more source

Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.

, 2005
BACKGROUND: Decisions about the use of killed oral cholera vaccines, which confer moderate levels of direct protection to vaccinees, can depend on whether the vaccines also provide indirect (herd) protection when high levels of vaccine coverage are ...
Ali, Mohammad, Sack, David A., Emch, Michael, Holmgren, Jan, Holmgren, Jan,, Clemens, John D, Rao, Malla, von Seidlein, Lorenz, Yunus, Mohammad, Clemens, John D., Sack, David A   +10 more
core   +1 more source

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency

Pathogens
A sharp rise in circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the years following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and the trend of seeding new emergences with suboptimal vaccination ...
Feyrouz Damji Kurji, Ananda Sankar Bandyopadhyay, Simona Zipursky, Laura V. Cooper, Chris Gast, Margaret Toher, Ralf Clemens, Sue Ann Costa Clemens, Rayasam Prasad, Adriansjah Azhari   +9 more
doaj   +1 more source

Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation. [PDF]

Front Public Health, 2023
Thompson KM, Kalkowska DA, Badizadegan K.   +2 more
europepmc   +1 more source

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation. [PDF]

Gates Open Res, 2023
Kalkowska DA, Wassilak SG, Wiesen E, F Estivariz C, Burns CC, Badizadegan K, Thompson KM.   +6 more
europepmc   +1 more source

The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi.

, 2005
BACKGROUND: The proportion of cases of tuberculosis due to recent infection can be estimated in long-term population-based studies using molecular techniques.
Yates, Malcolm D, Fine, Paul EM, Ngwira, Bagrey M., Traore, Hamidou, Crampin, Amelia C., Yates, Malcolm D., Fine, Paul E.M., Glynn, Judith R., Mwaungulu, Frank D., Glynn, Judith R, Mwaungulu, Frank D, Crampin, Amelia C, Drobniewski, Francis, Ndlovu, Richard, Ngwira, Bagrey M   +14 more
core   +1 more source